Tumor resistance in rats immunized to fetal tissues.

J. Grant,S. Wells

DOI: https://doi.org/10.1016/0022-4804(74)90080-8

IF: 2.417

1974-05-01

Journal of Surgical Research

Abstract:

What problem does this paper attempt to address?

GAPIT Version 2: an Enhanced Integrated Tool for Genomic Association and Prediction

You Tang,Xiaolei Liu,Jiabo Wang,Meng Li,Qishan Wang,Feng Tian,Zhongbin Su,Yuchun Pan,Di Liu,Alexander E. Lipka,Edward S. Buckler,Zhiwu Zhang

DOI: https://doi.org/10.3835/plantgenome2015.11.0120

2016-01-01

Abstract:Most human diseases and agriculturally important traits are complex. Dissecting their genetic architecture requires continued development of innovative and powerful statistical methods. Corresponding advances in computing tools are critical to efficiently use these statistical innovations and to enhance and accelerate biomedical and agricultural research and applications. The genome association and prediction integrated tool (GAPIT) was first released in 2012 and became widely used for genome-wide association studies (GWAS) and genomic prediction. The GAPIT implemented computationally efficient statistical methods, including the compressed mixed linear model (CMLM) and genomic prediction by using genomic best linear unbiased prediction (gBLUP). New state-of-the-art statistical methods have now been implemented in a new, enhanced version of GAPIT. These methods include factored spectrally transformed linear mixed models (FaST-LMM), enriched CMLM (ECMLM), FaST-LMM-Select, and settlement of mixed linear models under progressively exclusive relationship (SUPER). The genomic prediction methods implemented in this new release of the GAPIT include gBLUP based on CMLM, ECMLM, and SUPER. Additionally, the GAPIT was updated to improve its existing output display features and to add new data display and evaluation functions, including new graphing options and capabilities, phenotype simulation, power analysis, and cross-validation. These enhancements make the GAPIT a valuable resource for determining appropriate experimental designs and performing GWAS and genomic prediction. The enhanced R-based GAPIT software package uses state-of-the-art methods to conduct GWAS and genomic prediction. The GAPIT also provides new functions for developing experimental designs and creating publication-ready tabular summaries and graphs to improve the efficiency and application of genomic research.
HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics

Jie Zheng,Santiago Rodriguez,Charles Laurin,Denis Baird,Lea Trela-Larsen,Mesut A Erzurumluoglu,Yi Zheng,Jon White,Claudia Giambartolomei,Delilah Zabaneh,Richard Morris,Meena Kumari,Juan P Casas,Aroon D Hingorani,David M Evans,Tom R Gaunt,Ian N M Day,Mesut A. Erzurumluoglu,Juan P. Casas,Aroon D. Hingorani,David M. Evans,Tom R. Gaunt,Ian N. M. Day,

DOI: https://doi.org/10.1093/bioinformatics/btw565

IF: 5.8

2016-09-01

Bioinformatics

Abstract:MOTIVATION: Fine mapping is a widely used approach for identifying the causal variant(s) at disease-associated loci. Standard methods (e.g. multiple regression) require individual level genotypes. Recent fine mapping methods using summary-level data require the pairwise correlation coefficients ([Formula: see text]) of the variants. However, haplotypes rather than pairwise [Formula: see text], are the true biological representation of linkage disequilibrium (LD) among multiple loci. In this article, we present an empirical iterative method, HAPlotype Regional Association analysis Program (HAPRAP), that enables fine mapping using summary statistics and haplotype information from an individual-level reference panel.RESULTS: Simulations with individual-level genotypes show that the results of HAPRAP and multiple regression are highly consistent. In simulation with summary-level data, we demonstrate that HAPRAP is less sensitive to poor LD estimates. In a parametric simulation using Genetic Investigation of ANthropometric Traits height data, HAPRAP performs well with a small training sample size (N < 2000) while other methods become suboptimal. Moreover, HAPRAP's performance is not affected substantially by single nucleotide polymorphisms (SNPs) with low minor allele frequencies. We applied the method to existing quantitative trait and binary outcome meta-analyses (human height, QTc interval and gallbladder disease); all previous reported association signals were replicated and two additional variants were independently associated with human height. Due to the growing availability of summary level data, the value of HAPRAP is likely to increase markedly for future analyses (e.g. functional prediction and identification of instruments for Mendelian randomization).AVAILABILITY AND IMPLEMENTATION: The HAPRAP package and documentation are available at http://apps.biocompute.org.uk/haprap/ CONTACT: : jie.zheng@bristol.ac.uk or tom.gaunt@bristol.ac.ukSupplementary information: Supplementary data are available at Bioinformatics online.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
Discontinuation of enzyme replacement therapy in Fabry disease in the Dutch cohort.

M. Arends,G. Linthorst,C. Hollak,M. Biegstraaten

DOI: https://doi.org/10.1016/j.ymgme.2015.11.014

IF: 4.204

2016-02-01

Molecular Genetics and Metabolism

Abstract:
Development of a human genetics-guided priority score for 19,365 genes and 399 drug indications

Áine Duffy,Ben Omega Petrazzini,David Stein,Joshua K. Park,Iain S. Forrest,Kyle Gibson,Ha My Vy,Robert Chen,Carla Márquez-Luna,Matthew Mort,Marie Verbanck,Avner Schlessinger,Yuval Itan,David N. Cooper,Ghislain Rocheleau,Daniel M. Jordan,Ron Do

DOI: https://doi.org/10.1038/s41588-023-01609-2

IF: 30.8

2024-01-05

Nature Genetics

Abstract:Studies have shown that drug targets with human genetic support are more likely to succeed in clinical trials. Hence, a tool integrating genetic evidence to prioritize drug target genes is beneficial for drug discovery. We built a genetic priority score (GPS) by integrating eight genetic features with drug indications from the Open Targets and SIDER databases. The top 0.83%, 0.28% and 0.19% of the GPS conferred a 5.3-, 9.9- and 11.0-fold increased effect of having an indication, respectively. In addition, we observed that targets in the top 0.28% of the score were 1.7-, 3.7- and 8.8-fold more likely to advance from phase I to phases II, III and IV, respectively. Complementary to the GPS, we incorporated the direction of genetic effect and drug mechanism into a directional version of the score called the GPS with direction of effect. We applied our method to 19,365 protein-coding genes and 399 drug indications and made all results available through a web portal.

genetics & heredity
Openness weighted association studies: leveraging personal genome information to prioritize non-coding variants

Shuang Song,Nayang Shan,Geng Wang,Xiting Yan,Jun S Liu,Lin Hou

DOI: https://doi.org/10.1093/bioinformatics/btab514

IF: 5.8

2021-07-14

Bioinformatics

Abstract:Abstract Motivation Identification and interpretation of non-coding variations that affect disease risk remain a paramount challenge in genome-wide association studies (GWAS) of complex diseases. Experimental efforts have provided comprehensive annotations of functional elements in the human genome. On the other hand, advances in computational biology, especially machine learning approaches, have facilitated accurate predictions of cell-type-specific functional annotations. Integrating functional annotations with GWAS signals has advanced the understanding of disease mechanisms. In previous studies, functional annotations were treated as static of a genomic region, ignoring potential functional differences imposed by different genotypes across individuals. Results We develop a computational approach, Openness Weighted Association Studies (OWAS), to leverage and aggregate predictions of chromosome accessibility in personal genomes for prioritizing GWAS signals. The approach relies on an analytical expression we derived for identifying disease associated genomic segments whose effects in the etiology of complex diseases are evaluated. In extensive simulations and real data analysis, OWAS identifies genes/segments that explain more heritability than existing methods, and has a better replication rate in independent cohorts than GWAS. Moreover, the identified genes/segments show tissue-specific patterns and are enriched in disease relevant pathways. We use rheumatic arthritis and asthma as examples to demonstrate how OWAS can be exploited to provide novel insights on complex diseases. Availability and implementation The R package OWAS that implements our method is available at https://github.com/shuangsong0110/OWAS. Supplementary information Supplementary data are available at Bioinformatics online.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
An effector index to predict target genes at GWAS loci

Vincenzo Forgetta,Lai Jiang,Nicholas A. Vulpescu,Megan S. Hogan,Siyuan Chen,John A. Morris,Stepan Grinek,Christian Benner,Dong-Keun Jang,Quy Hoang,Noel Burtt,Jason A. Flannick,Mark I. McCarthy,Eric Fauman,Celia M. T. Greenwood,Matthew T. Maurano,J. Brent Richards

DOI: https://doi.org/10.1007/s00439-022-02434-z

2022-02-11

Human Genetics

Abstract:Drug development and biological discovery require effective strategies to map existing genetic associations to causal genes. To approach this problem, we selected 12 common diseases and quantitative traits for which highly powered genome-wide association studies (GWAS) were available. For each disease or trait, we systematically curated positive control gene sets from Mendelian forms of the disease and from targets of medicines used for disease treatment. We found that these positive control genes were highly enriched in proximity of GWAS-associated single-nucleotide variants (SNVs). We then performed quantitative assessment of the contribution of commonly used genomic features, including open chromatin maps, expression quantitative trait loci (eQTL), and chromatin conformation data. Using these features, we trained and validated an Effector Index (Ei), to map target genes for these 12 common diseases and traits. Ei demonstrated high predictive performance, both with cross-validation on the training set, and an independently derived set for type 2 diabetes. Key predictive features included coding or transcript-altering SNVs, distance to gene, and open chromatin-based metrics. This work outlines a simple, understandable approach to prioritize genes at GWAS loci for functional follow-up and drug development, and provides a systematic strategy for prioritization of GWAS target genes.

genetics & heredity
WikiGWA: an Open Platform for Collecting and Using Genome-Wide Association Results

Huang, Jie,Liu, Eric Y,Welch, Ryan,Willer, Cristen,Hindorff, Lucia A,Li, Yun

DOI: https://doi.org/10.1038/ejhg.2012.187

2013-01-01

European Journal of Human Genetics

Abstract:The number of discovered genetic variants from genome-wide association (GWA) studies (GWAS) has been growing rapidly. Centralized efforts such as the National Human Genome Research Institute’s GWAS catalog provide regular updates and a convenient interface for quick lookup. However, the catalog entries are manually curated and rely on data from published articles. Other tools such as SNPedia ( http://www.snpedia.com ) collect published results regarding functional consequences of genetic variations. Here, we propose an approach that allows individual investigators to share their GWA results through an open platform. Unlike GWAS catalog or SNPedia, wikiGWA collects first-hand GWAS results and in a much larger scale. Investigators are not only able to post a much larger amount of results, but also post results from unpublished studies, which could alleviate publication bias and facilitate identification of weak signals. Our interface allows for flexible and fast queries, and the query results are formatted to work seamlessly with the LocusZoom program for visualization and annotation. We here describe wikiGWA, made publically available at http://www.wikiGWA.org .
TargetSNPdb: a database of preliminary analysis data of the impact of nsSNPs on drug target, drug metabolizing enzyme and disease associated genes

Julio CD Lopes,Sergio A Alencar,Eduardo C Santos,Andrelly Martins-José

DOI: https://doi.org/10.26434/chemrxiv-2024-8nhvq-v2

2024-04-10

Abstract:Motivation: The presence of nsSNPs in genes encoding drug targets, or drug metabolizing enzymes has been increasingly associated with drug response and diseases. The use of computational tools to analyze sequence and structure data of proteins can contribute to increase prediction efficiency of the impact caused by these nsSNPs. Results: We have developed TargetSNPdb, a database server that contains computational predictions of the structural and functional impact of nsSNPs in protein coding genes, including drug target and drug metabolizing enzyme encoding genes. The analysis results obtained from several computational tools (such as SIFT, PolyPhen, AutoDock, and GROMACS) relevant to the study of the impact of amino acid residue substitutions were integrated to existent information records from the literature and genetic association databases, enabling the combination of results from a variety of different approaches to evaluate the potential impact of nsSNPs on protein function. Potential applications of TargetSNPdb include the priorization of nsSNPs for association and experimental studies. Availability: The TargetSNPdb can be accessed via http://nequim.qui.ufmg.br/targetsnp/

Chemistry
GWGGI: software for genome-wide gene-gene interaction analysis

Changshuai Wei,Qing Lu

DOI: https://doi.org/10.48550/arXiv.1505.01187

2015-05-05

Quantitative Methods

Abstract:Background: While the importance of gene-gene interactions in human diseases has been well recognized, identifying them has been a great challenge, especially through association studies with millions of genetic markers and thousands of individuals. Computationally efficient and powerful tools are in great need for the identification of new gene-gene interactions in high-dimensional association studies. Result: We develop C++ software for genome-wide gene-gene interaction analyses (GWGGI). GWGGI utilizes tree-based algorithms to search a large number of genetic markers for a disease-associated joint association with the consideration of high-order interactions, and then uses non-parametric statistics to test the joint association. The package includes two functions, likelihood ratio Mann-whitney (LRMW) and Tree Assembling Mann-whitney (TAMW).We optimize the data storage and computational efficiency of the software, making it feasible to run the genome-wide analysis on a personal computer. The use of GWGGI was demonstrated by using two real data-sets with nearly 500 k genetic markers. Conclusion: Through the empirical study, we demonstrated that the genome-wide gene-gene interaction analysis using GWGGI could be accomplished within a reasonable time on a personal computer (i.e., ~3.5 hours for LRMW and ~10 hours for TAMW). We also showed that LRMW was suitable to detect interaction among a small number of genetic variants with moderate-to-strong marginal effect, while TAMW was useful to detect interaction among a larger number of low-marginal-effect genetic variants.
Large-Scale Validation of Single Nucleotide Polymorphisms in Gene Regions

Matthew R Nelson,George Marnellos,Stefan Kammerer,Carolyn R Hoyal,Michael M Shi,Charles R Cantor,Andreas Braun,Matthew R. Nelson,Carolyn R. Hoyal,Michael M. Shi,Charles R. Cantor

DOI: https://doi.org/10.1101/gr.2421604

IF: 9.438

2004-08-01

Genome Research

Abstract:Genome-wide association studies using large numbers of bi-allelic single nucleotide polymorphisms (SNPs) have been proposed as a potentially powerful method for identifying genes involved in common diseases. To assemble a SNP collection appropriate for large-scale association, we designed assays for 226,099 publicly available SNPs located primarily within known and predicted gene regions. Allele frequencies were estimated in a sample of 92 CEPH Caucasians using chip-based MALDI-TOF mass spectrometry with pooled DNA. Of the 204,200 designed assays that were functional, 125,799 SNPs were determined to be polymorphic (minor allele frequency >0.02), of which 101,729 map uniquely to the human genome. Many of the commonly available RefSNP annotations were predictive of polymorphic status and could be used to improve the selection of SNPs from the public domain for genetic research. The set of uniquely mapping, polymorphic SNPs is located within 10 kb of 66% of known and predicted genes annotated in LocusLink, which could prove useful for large-scale disease association studies.

genetics & heredity,biochemistry & molecular biology,biotechnology & applied microbiology
Continuous Gastric Decompression for Postoperative Nausea and Vomiting After Coronary Revascularization Surgery

C. Burlacu,D. Healy,D. Buggy,Ciaran F. Twomey,David Veerasingam,A. Tierney,D. Moriarty

DOI: https://doi.org/10.1213/01.ANE.0000143567.51304.1A

2005-02-01

Abstract:Postoperative nausea and vomiting is common after cardiac surgery and may contribute to significant morbidity. Gastric decompression during anesthesia has been used for postoperative nausea and vomiting prophylaxis in shorter duration noncardiac surgery with conflicting results. We tested the hypothesis that gastric decompression during elective coronary revascularization surgery with cardiopulmonary bypass and continued afterwards until tracheal extubation would reduce the incidence of vomiting or retching and nausea. In a prospective, randomized, cohort study, 104 patients with at least 2 Apfel’s risk factors for postoperative nausea and vomiting were allocated to receive a gastric tube on free gravity drainage after induction of anesthesia (n = 52) or to a control group (n = 52). The gastric tube was removed simultaneously with tracheal extubation postoperatively. The primary outcome measure was the incidence of vomiting or retching. Secondary outcomes included the incidence and severity of nausea measured on a visual analog scale. The incidence of vomiting or retching was 13.4% in patients with gastric decompression, compared with 11.5% in the control group (P = 0.7). Similarly, there was no statistically significant difference between the two groups in the incidence of nausea (32.7% versus 25.0%, P = 0.6), median severity of nausea on a visual analog scale at 12 h (25; range, 0–55 mm versus 30; range, 0–60 mm, P = 0.4), or antiemetics administration (38.5% versus 28.8%, P = 0.3). Continuous gastric decompression during coronary revascularization surgery and afterwards until tracheal extubation did not reduce the incidence of vomiting or retching or the incidence and severity of nausea in these patients.
PAGEANT: Personal Access to Genome and Analysis of Natural Traits

Jie Huang,Zhi-Sheng Liang,Stefano Pallotti,Janice M. Ranson,David J. Llewellyn,Zhi-Jie Zheng,Daniel A. King,Qiang Zhou,Houfeng Zheng,Valerio Napolioni

DOI: https://doi.org/10.1093/nar/gkab1245

IF: 14.9

2022-01-01

Nucleic Acids Research

Abstract:GWASs have identified numerous genetic variants associated with a wide variety of diseases, yet despite the wide availability of genetic testing the insights that would enhance the interpretability of these results are not widely available to members of the public. As a proof of concept and demonstration of technological feasibility, we developed PAGEANT (Personal Access to Genome & Analysis of Natural Traits), usable through Graphical User Interface or command line-based version, aiming to serve as a protocol and prototype that guides the overarching design of genetic reporting tools. PAGEANT is structured across five core modules, summarized by five Qs: (i) quality assurance of the genetic data; (ii) qualitative assessment of genetic characteristics; (iii) quantitative assessment of health risk susceptibility based on polygenic risk scores and population reference; (iv) query of third-party variant databases (e.g. ClinVAR and PharmGKB) and (v) quick Response code of genetic variants of interest. Literature review was conducted to compare PAGEANT with academic and industry tools. For 2504 genomes made publicly available through the 1000 Genomes Project, we derived their genomic characteristics for a suite of qualitative and quantitative traits. One exemplary trait is susceptibility to COVID-19, based on the most up-to-date scientific findings reported.
GWAShug: a comprehensive platform for decoding the shared genetic basis between complex traits based on summary statistics

Chen Cao,Min Tian,Zhenghui Li,Wenyan Zhu,Peng Huang,Sheng Yang

DOI: https://doi.org/10.1093/nar/gkae873

IF: 14.9

2024-10-10

Nucleic Acids Research

Abstract:The shared genetic basis offers very valuable insights into the etiology, diagnosis and therapy of complex traits. However, a comprehensive resource providing shared genetic basis using the accessible summary statistics is currently lacking. It is challenging to analyze the shared genetic basis due to the difficulty in selecting parameters and the complexity of pipeline implementation. To address these issues, we introduce GWAShug, a platform featuring a standardized best-practice pipeline with four trait level methods and three molecular level methods. Based on stringent quality control, the GWAShug resource module includes 539 high-quality GWAS summary statistics for European and East Asian populations, covering 54 945 pairs between a measurement-based and a disease-based trait and 43 902 pairs between two disease-based traits. Users can easily search for shared genetic basis information by trait name, MeSH term and category, and access detailed gene information across different trait pairs. The platform facilitates interactive visualization and analysis of shared genetic basic results, allowing users to explore data dynamically. Results can be conveniently downloaded via FTP links. Additionally, we offer an online analysis module that allows users to analyze their own summary statistics, providing comprehensive tables, figures and interactive visualization and analysis. GWAShug is freely accessible at http://www.gwashug.com.

biochemistry & molecular biology
GPA: A Statistical Approach to Prioritizing GWAS Results by Integrating Pleiotropy and Annotation

Dongjun Chung,Can Yang,Cong Li,Joel Gelernter,Hongyu Zhao

DOI: https://doi.org/10.1371/journal.pgen.1004787

IF: 4.5

2014-11-13

PLoS Genetics

Abstract:Results from Genome-Wide Association Studies (GWAS) have shown that complex diseases are often affected by many genetic variants with small or moderate effects. Identifications of these risk variants remain a very challenging problem. There is a need to develop more powerful statistical methods to leverage available information to improve upon traditional approaches that focus on a single GWAS dataset without incorporating additional data. In this paper, we propose a novel statistical approach, GPA (Genetic analysis incorporating Pleiotropy and Annotation), to increase statistical power to identify risk variants through joint analysis of multiple GWAS data sets and annotation information because: (1) accumulating evidence suggests that different complex diseases share common risk bases, i.e., pleiotropy; and (2) functionally annotated variants have been consistently demonstrated to be enriched among GWAS hits. GPA can integrate multiple GWAS datasets and functional annotations to seek association signals, and it can also perform hypothesis testing to test the presence of pleiotropy and enrichment of functional annotation. Statistical inference of the model parameters and SNP ranking is achieved through an EM algorithm that can handle genome-wide markers efficiently. When we applied GPA to jointly analyze five psychiatric disorders with annotation information, not only did GPA identify many weak signals missed by the traditional single phenotype analysis, but it also revealed relationships in the genetic architecture of these disorders. Using our hypothesis testing framework, statistically significant pleiotropic effects were detected among these psychiatric disorders, and the markers annotated in the central nervous system genes and eQTLs from the Genotype-Tissue Expression (GTEx) database were significantly enriched. We also applied GPA to a bladder cancer GWAS data set with the ENCODE DNase-seq data from 125 cell lines. GPA was able to detect cell lines that are biologically more relevant to bladder cancer. The R implementation of GPA is currently available at http://dongjunchung.github.io/GPA/.

genetics & heredity
SNPnotes: high-throughput tissue-specific functional annotation of single nucleotide variants

Shraddha Pai,Michael J. Apostolides,Andrew Jung,Matthew A. Moss

DOI: https://doi.org/10.12688/f1000research.20415.1

2019-10-22

F1000Research

Abstract:A key challenge in the application of whole-genome sequencing (WGS) for clinical diagnostic and research is the high-throughput prioritization of functional variants in the non-coding genome. This challenge is compounded by context-specific genetic modulation of gene expression, and variant-gene mapping depends on the tissues and organ systems affected in a given disease; for instance, a disease affecting the gastrointestinal system would use maps specific to genome regulation in gut-related tissues. While there are large-scale atlases of genome regulation, such as GTEx and NIH Roadmap Epigenomics, the clinical genetics community lacks publicly-available stand-alone software for high-throughput annotation of custom variant data with user-defined tissue-specific epigenetic maps and clinical genetic databases, to prioritize variants for a specific biomedical application. In this work, we provide a simple software pipeline, called SNPnotes, which takes as input variant calls for a patient and prioritizes those using information on clinical relevance from ClinVar, tissue-specific gene regulation from GTEx and disease associations from the NHGRI-EBI GWAS catalogue. This pipeline was developed as part of SVAI Research's "Undiagnosed-1" event for collaborative patient diagnosis. We applied this pipeline to WGS-based variant calls for an individual with a history of gastrointestinal symptoms, using 12 gut-specific eQTL maps and GWAS associations for metabolic diseases, for variant-gene mapping. Out of 6,248,584 SNPs, the pipeline identified 151 high-priority variants, overlapping 129 genes. These top SNPs all have known clinical pathogenicity, modulate gene expression in gut tissues and have genetic associations with metabolic disorders, and serve as starting points for hypotheses about mechanisms driving clinical symptoms. Simple software changes can be made to customize the pipeline for other tissue-specific applications. Future extensions could integrate maps of tissue-specific regulatory elements, higher-order chromatin loops, and mutations affecting splice variants.
HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease

Lucas D. Ward,Manolis Kellis

DOI: https://doi.org/10.1093/nar/gkv1340

IF: 14.9

2015-12-10

Nucleic Acids Research

Abstract:More than 90% of common variants associated with complex traits do not affect proteins directly, but instead the circuits that control gene expression. This has increased the urgency of understanding the regulatory genome as a key component for translating genetic results into mechanistic insights and ultimately therapeutics. To address this challenge, we developed HaploReg (http://compbio.mit.edu/HaploReg) to aid the functional dissection of genome-wide association study (GWAS) results, the prediction of putative causal variants in haplotype blocks, the prediction of likely cell types of action, and the prediction of candidate target genes by systematic mining of comparative, epigenomic and regulatory annotations. Since first launching the website in 2011, we have greatly expanded HaploReg, increasing the number of chromatin state maps to 127 reference epigenomes from ENCODE 2012 and Roadmap Epigenomics, incorporating regulator binding data, expanding regulatory motif disruption annotations, and integrating expression quantitative trait locus (eQTL) variants and their tissue-specific target genes from GTEx, Geuvadis, and other recent studies. We present these updates as HaploReg v4, and illustrate a use case of HaploReg for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putative brain regulatory mechanisms.

biochemistry & molecular biology
Supplementary Material For: Inferring Gene-Disease Association by an Integrative Analysis of Eqtl Genome-Wide Association Study and Protein-Protein Interaction Data

Jing Wang,Jingwen Zheng,Zhenzhen Wang,Li H,Minghua Deng

DOI: https://doi.org/10.6084/m9.figshare.7599017

2019-01-01

Abstract:Objectives: Genome-wide association studies (GWASs) have revealed many candidate SNPs, but the mechanisms by which these SNPs influence diseases are largely unknown. In order to decipher the underlying mechanisms, several methods have been developed to predict disease-associated genes based on the integration of GWAS and eQTL data (e.g., Sherlock and COLOC). A number of studies have also incorporated information from gene networks into GWAS analysis to reprioritize candidate genes. Methods: Motivated by these two different approaches, we have developed a statistical framework to integrate information from GWAS, eQTL, and protein-protein interaction (PPI) data to predict disease-associated genes. Our approach is based on a hidden Markov random field (HMRF) model, and we called the resulting computational algorithm GeP-HMRF (a GWAS-eQTL-PPI-based HMRF). Results: We compared the performance of GeP-HMRF with Sherlock, COLOC, and NetWAS methods on 9 GWAS datasets, using the disease-related genes in the MalaCards database as the standard, and found that GeP-HMRF significantly improves the prediction accuracy. We also applied GeP-HMRF to an age-related macular degeneration disease (AMD) dataset. Among the top 50 genes predicted by GeP-HMRF, 7 are reported by the MalaCards database to be AMD-related with an enrichment p value of 3.61 × 10–119. Among the top 20 genes predicted by GeP-HMRF, CFHR1, CGHR3, HTRA1, and CFH are AMD-related in the MalaCards database, and another 9 genes are supported by the literature. Conclusions: We built a unified statistical model to predict disease-related genes by integrating GWAS, eQTL, and PPI data. Our approach outperforms Sherlock, COLOC, and NetWAS in simulation studies and 9 GWAS datasets. Our approach can be generalized to incorporate other molecular trait data beyond eQTL and other interaction data beyond PPI.
An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci

Edward Mountjoy,Ellen M. Schmidt,Miguel Carmona,Jeremy Schwartzentruber,Gareth Peat,Alfredo Miranda,Luca Fumis,James Hayhurst,Annalisa Buniello,Mohd Anisul Karim,Daniel Wright,Andrew Hercules,Eliseo Papa,Eric B. Fauman,Jeffrey C. Barrett,John A. Todd,David Ochoa,Ian Dunham,Maya Ghoussaini

DOI: https://doi.org/10.1038/s41588-021-00945-5

IF: 30.8

2021-10-28

Nature Genetics

Abstract:Genome-wide association studies (GWASs) have identified many variants associated with complex traits, but identifying the causal gene(s) is a major challenge. In the present study, we present an open resource that provides systematic fine mapping and gene prioritization across 133,441 published human GWAS loci. We integrate genetics (GWAS Catalog and UK Biobank) with transcriptomic, proteomic and epigenomic data, including systematic disease–disease and disease–molecular trait colocalization results across 92 cell types and tissues. We identify 729 loci fine mapped to a single-coding causal variant and colocalized with a single gene. We trained a machine-learning model using the fine-mapped genetics and functional genomics data and 445 gold-standard curated GWAS loci to distinguish causal genes from neighboring genes, outperforming a naive distance-based model. Our prioritized genes were enriched for known approved drug targets (odds ratio = 8.1, 95% confidence interval = 5.7, 11.5). These results are publicly available through a web portal (http://genetics.opentargets.org), enabling users to easily prioritize genes at disease-associated loci and assess their potential as drug targets.

genetics & heredity
Integrate multiple traits to detect novel trait–gene association using GWAS summary data with an adaptive test approach

Bin Guo,Baolin Wu

DOI: https://doi.org/10.1093/bioinformatics/bty961

IF: 5.8

2018-11-23

Bioinformatics

Abstract:Abstract Motivation Genetics hold great promise to precision medicine by tailoring treatment to the individual patient based on their genetic profiles. Toward this goal, many large-scale genome-wide association studies (GWAS) have been performed in the last decade to identify genetic variants associated with various traits and diseases. They have successfully identified tens of thousands of disease-related variants. However they have explained only a small proportion of the overall trait heritability for most traits and are of very limited clinical use. This is partly owing to the small effect sizes of most genetic variants, and the common practice of testing association between one trait and one genetic variant at a time in most GWAS, even when multiple related traits are often measured for each individual. Increasing evidence suggests that many genetic variants can influence multiple traits simultaneously, and we can gain more power by testing association of multiple traits simultaneously. It is appealing to develop novel multi-trait association test methods that need only GWAS summary data, since it is generally very hard to access the individual-level GWAS phenotype and genotype data. Results Many existing GWAS summary data-based association test methods have relied on ad hoc approach or crude Monte Carlo approximation. In this article, we develop rigorous statistical methods for efficient and powerful multi-trait association test. We develop robust and efficient methods to accurately estimate the marginal trait correlation matrix using only GWAS summary data. We construct the principal component (PC)-based association test from the summary statistics. PC-based test has optimal power when the underlying multi-trait signal can be captured by the first PC, and otherwise it will have suboptimal performance. We develop an adaptive test by optimally weighting the PC-based test and the omnibus chi-square test to achieve robust performance under various scenarios. We develop efficient numerical algorithms to compute the analytical P-values for all the proposed tests without the need of Monte Carlo sampling. We illustrate the utility of proposed methods through application to the GWAS meta-analysis summary data for multiple lipids and glycemic traits. We identify multiple novel loci that were missed by individual trait-based association test. Availability and implementation All the proposed methods are implemented in an R package available at http://www.github.com/baolinwu/MTAR. The developed R programs are extremely efficient: it takes less than 2 min to compute the list of genome-wide significant single nucleotide polymorphisms (SNPs) for all proposed multi-trait tests for the lipids GWAS summary data with 2.5 million SNPs on a single Linux desktop. Supplementary information Supplementary data are available at Bioinformatics online.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
GWASdb v2: an update database for human genetic variants identified by genome-wide association studies

Mulin Jun Li,Zipeng Liu,Panwen Wang,Maria P. Wong,Matthew R. Nelson,Jean-Pierre A. Kocher,Meredith Yeager,Pak Chung Sham,Stephen J. Chanock,Zhengyuan Xia,Junwen Wang

DOI: https://doi.org/10.1093/nar/gkv1317

IF: 14.9

2015-11-28

Nucleic Acids Research

Abstract:Genome-wide association studies (GWASs), now as a routine approach to study single-nucleotide polymorphism (SNP)-trait association, have uncovered over ten thousand significant trait/disease associated SNPs (TASs). Here, we updated GWASdb (GWASdb v2, http://jjwanglab.org/gwasdb) which provides comprehensive data curation and knowledge integration for GWAS TASs. These updates include: (i) Up to August 2015, we collected 2479 unique publications from PubMed and other resources; (ii) We further curated moderate SNP-trait associations (P-value < 1.0 × 10(-3)) from each original publication, and generated a total of 252,530 unique TASs in all GWASdb v2 collected studies; (iii) We manually mapped 1610 GWAS traits to 501 Human Phenotype Ontology (HPO) terms, 435 Disease Ontology (DO) terms and 228 Disease Ontology Lite (DOLite) terms. For each ontology term, we also predicted the putative causal genes; (iv) We curated the detailed sub-populations and related sample size for each study; (v) Importantly, we performed extensive function annotation for each TAS by incorporating gene-based information, ENCODE ChIP-seq assays, eQTL, population haplotype, functional prediction across multiple biological domains, evolutionary signals and disease-related annotation; (vi) Additionally, we compiled a SNP-drug response association dataset for 650 pharmacogenetic studies involving 257 drugs in this update; (vii) Last, we improved the user interface of website.

biochemistry & molecular biology

Tumor resistance in rats immunized to fetal tissues.

GAPIT Version 2: an Enhanced Integrated Tool for Genomic Association and Prediction

HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics

Discontinuation of enzyme replacement therapy in Fabry disease in the Dutch cohort.

Development of a human genetics-guided priority score for 19,365 genes and 399 drug indications

Openness weighted association studies: leveraging personal genome information to prioritize non-coding variants

An effector index to predict target genes at GWAS loci

WikiGWA: an Open Platform for Collecting and Using Genome-Wide Association Results

TargetSNPdb: a database of preliminary analysis data of the impact of nsSNPs on drug target, drug metabolizing enzyme and disease associated genes

GWGGI: software for genome-wide gene-gene interaction analysis

Large-Scale Validation of Single Nucleotide Polymorphisms in Gene Regions

Continuous Gastric Decompression for Postoperative Nausea and Vomiting After Coronary Revascularization Surgery

PAGEANT: Personal Access to Genome and Analysis of Natural Traits

GWAShug: a comprehensive platform for decoding the shared genetic basis between complex traits based on summary statistics

GPA: A Statistical Approach to Prioritizing GWAS Results by Integrating Pleiotropy and Annotation

SNPnotes: high-throughput tissue-specific functional annotation of single nucleotide variants

HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease

Supplementary Material For: Inferring Gene-Disease Association by an Integrative Analysis of Eqtl Genome-Wide Association Study and Protein-Protein Interaction Data

An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci

Integrate multiple traits to detect novel trait–gene association using GWAS summary data with an adaptive test approach

GWASdb v2: an update database for human genetic variants identified by genome-wide association studies